The Anticancer Effects of Novel Imidazo[1,2-a]Pyridine Compounds against HCC1937 Breast Cancer Cells

BACKGROUND: Anticancer drugs confront clinical obstacles such as drug resistance and adverse effects. Imidazo[1,2-a]pyridines (IPs) compounds have lately gained considerable interest as possible anticancer therapeutics due to their potent inhibitory function against cancers cells. This study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Altaher, Akram M, Adris, Mohammed A, Aliwaini, Saeb H, Awadallah, Adel M, Morjan, Rami Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810306/
https://www.ncbi.nlm.nih.gov/pubmed/36172656
http://dx.doi.org/10.31557/APJCP.2022.23.9.2943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810306/
https://www.ncbi.nlm.nih.gov/pubmed/36172656
http://dx.doi.org/10.31557/APJCP.2022.23.9.2943

Ejemplares similares